Search Results for 'ovarian cancer screening'

There are many places you can go online to learn more about cancer and obtain financial and psycho-social support. Here are a few examples: 21st Century C.A.R.E. (888-850-1622) – Provides financial assistance, education and support. American Cancer Society (800-227-2345) – … Read more

Symptoms Early detection of ovarian cancer is challenging because symptoms can be mild and vague and could apply to a variety of conditions, such as irritable bowel syndrome or ovarian cysts. However, the most typical ovarian cancer symptoms, or changes … Read more

Tumor biomarker testing can help inform treatment decisions for ovarian cancer patients.  This information is discovered by testing the tumor for biomarkers, such as PD-L1, homologous recombination deficiency (HRD), tumor mutation burden (TMB), and microsatellite instability (MSI) and using next … Read more

by Josh Friedman Key takeaways: AI-analyzed fragmentomes and protein biomarkers better distinguished women with ovarian cancer in screening. Liquid biopsy assay outperformed CA125 analysis alone. An artificial intelligence-driven algorithm used a novel liquid biopsy assay to differentiate women with ovarian … Read more

By Heidi Splete Many women with cancer want advice for managing sexual function issues, and clinicians are tuning in, new studies suggest. Decreased sexual function is a side effect of many types of cancer, notably uterine, cervical, ovarian, and breast … Read more

By Mike Basset Risk management strategies including bilateral salpingo-oophorectomy (BSO) for ovarian cancer and MRI surveillance for breast cancer were associated with a significant reduction in mortality for women with BRCA1/2 sequence variations, according to results from two cohort studies … Read more

By Fay Lin, PhD A major bottleneck in early detection is the molecular heterogeneity between ovarian cancer (OC) patients, which limits the likelihood of identifying individual biomarkers that are shared among patients. In a new study “A personalized probabilistic … Read more

By Mark Fuerst Direct-to-consumer (DTC) genetic testing has limited use as a screening tool for identifying individuals at risk of hereditary breast or ovarian cancer, especially in those of non-Ashkenazi Jewish descent, researchers reported. Most current DTC genetic tests evaluate … Read more

By Sharon Reynolds Clearity offers psychosocial support to caregivers through our Steps Through OC program. If you would like personal one-to-one assistance with the stress and challenges associated with caring for a loved one with an ovarian cancer diagnosis, our … Read more

By Hayden E. Klein For Ovarian Cancer Awareness Month in September, Rebecca Brooks, MD, talked to The American Journal of Managed Care® (AJMC®) about how genetics and family history play a large role in ovarian cancer … Read more

Ovarian cancer is particularly difficult to detect, as the disease often does not produce significant symptoms until it has reached late stages and caused metastasis. New screening methods would help physicians detect ovarian tumors early and dramatically increase the chances … Read more

A new study describes a new diagnostic approach that could help identify the 15% of women with ovarian cancer whose tumors are intrinsically refractory to standard platinum-based therapies, the most common type of chemotherapy for the disease. Most ovarian cancers … Read more

Key Points: Interim results of the phase 2 trial DESTINY-PanTumor-02 show that T-DXd has broad activity across tumor types and a toxicity profile consistent with previous studies. T-DXd had the lowest activity in pancreatic cancer, and this cohort was stopped … Read more

by Jennifer Southall Whole-exome sequencing identified carriers of predisposition genes for hereditary breast and ovarian cancer or Lynch syndrome who, under current guidelines, would not have qualified for genetic testing, according to study results. The findings, presented at American Association … Read more

by Alison Kanski NEW YORK – Personalized phone discussions about genetic risk assessment increased the number of breast and ovarian cancer patients who got genetic testing or discussed their risk with a genetic counselor, a study from Rutgers Cancer Institute … Read more

by Jo Cavallo The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) has shown that general population screening did not significantly reduce ovarian and tubal cancer deaths, and the researchers concluded that such screening cannot be recommended. The findings from … Read more

by Anita T. Shaffer Efforts to target the folate metabolism network have entered a new stage, with the approval of a novel therapy directed at folate receptor–α and the potential for additional agents aimed at that target in solid tumors.… Read more

by Beth Miller (From left) The top row shows an ultrasound image of a malignant lesion, the blood oxygen saturation, and hemoglobin concentration. The bottom row is an ultrasound image of a benign lesion, the blood oxygen saturation, and hemoglobin … Read more

by Chris Ryan Treatment with mirvetuximab soravtansine elicited a statistically significant benefit vs investigator’s choice of chemotherapy for the OV28 abdominal/gastrointestinal symptom subscale in patients with folate receptor alpha–positive, advanced ovarian cancer. Treatment with mirvetuximab soravtansine elicited a statistically significant … Read more

by Cedars-Sinai New Studies Led by Cedars-Sinai Investigators Help Pinpoint Genetic Risk Factors Tied to Increased Risk of Ovarian Cancer and Suggest How to Better Identify Women Most At Risk Image on left: Simon Gayther, PhD, professor of Biomedical Sciences, … Read more